Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jason Mullins

Physician Assistant, Medical Catlettsburg, KY Physician Assistant

NPI 1699146100 CMS profile 11118217

4004 Louisa Road, Catlettsburg, KY 41129

Open in the dashboard

General payments

$8,258

487 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jason Mullins of Catlettsburg, KY is reported in the CMS Open Payments database as having received $8,258 across 487 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,383 123
2024 General $2,196 121
2023 General $1,712 109
2022 General $991 74
2021 General $975 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Mullins
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Jason Mullins were reported at $2,383. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Jason Mullins Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $975 $156 $41–$563 $132
2022 $991 $185 $55–$649 $149
2023 $1,712 $199 $58–$717 $160
2024 $2,196 $206 $62–$740 $164
2025 $2,383 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novo Nordisk Inc $1,215 75 payments
  2. AbbVie, Inc. $789 51 payments
  3. Pfizer Inc. $773 53 payments
  4. Lilly USA, LLC $550 34 payments
  5. GlaxoSmithKline, LLC. $532 32 payments
  6. AstraZeneca Pharmaceuticals LP $462 20 payments
  7. Janssen Pharmaceuticals, Inc $363 14 payments
  8. Vanda Pharmaceuticals Inc. $271 11 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $253 15 payments
  10. Novartis Pharmaceuticals Corporation $238 14 payments
  11. Other $2,812 168 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,258 487 payments
Products named General payments · program years 2021–2025
  1. Ozempic $681 40 payments
  2. RYBELSUS $681 40 payments
  3. NURTEC ODT $628 43 payments
  4. TRELEGY ELLIPTA $485 28 payments
  5. UBRELVY $426 23 payments
  6. ZAVZPRET $352 23 payments
  7. QULIPTA $352 17 payments
  8. AIRSUPRA $333 12 payments
  9. Wegovy $312 21 payments
  10. FANAPT $271 11 payments
  11. Other $5,942 358 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 77 drugs

Part D claims

2,483

Median for Physician Assistant: 241

Drug cost

$195,579

Median for Physician Assistant: $4,110

Branded share of claims

15.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 52 $42,221
Jardiance Empagliflozin Brand 35 $35,139
Ozempic Semaglutide Brand 30 $30,679
Xarelto Rivaroxaban Brand 17 $17,688
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 21 $13,812
Linzess Linaclotide Brand 13 $11,449
Farxiga Dapagliflozin Propanediol Brand 12 $10,649
Brilinta Ticagrelor Brand 14 $4,766
Tizanidine Hcl Generic 16 $3,984
Metaxalone Generic 13 $2,600

The 10 drugs with the highest cost, of 77 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$30,643

Of which drugs: $3,551

Medicare patients

140

Average age 73

Services billed

505

81 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 46%
Diabetes 36%
Ischemic heart disease 29%
Chronic kidney disease 27%
Depression 22%
Atrial fibrillation 21%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Vaccine for influenza for injection into muscle 90662 Office 11 11 $900

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 34 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $118
  • Lilly USA, LLC $64
$182 35 —
VOQUEZNA
  • Phathom Pharmaceuticals, Inc. $152
$152 — —
UBRELVY
  • AbbVie, Inc. $140
$140 — —
QULIPTA
  • AbbVie, Inc. $137
$137 — —
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $128
$128 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 34 with Patron

Records

487 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record